Castration-resistant prostate cancer: latest evidence and therapeutic implications

This article reviews the approved therapies for CRPC, the agents currently in late-phase clinical trials, and notable early-phase trials of novel therapies and their combinations, with particular attention to trials incorporating novel biomarkers and intermediate endpoints to better identify those men who may or may not benefit from specific therapies.
Source: Therapeutic Advances in Medical Oncology - Category: Cancer & Oncology Authors: Tags: Reviews Source Type: research